Clinical Trials Browser

Phase 2 × INDUSTRY × eculizumab × Clear all

NCT00727194 2019-09-24

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

Phase 2 Terminated

14 enrolled 23 charts

Myasthenia Gravis